Conversation with Our Stock Selection Team, Part One Introduction One of my favorite aspects of working at RiverFront is working with four associate portfolio managers that make up our equity selection team. This team performs analysis on individual equities that provides useful insights into how we position our portfolios. Team Collaboration Collaborating with our stock…
Upcoming Deadline for PACS Group Inc. Investors Reminder from Glancy Prongay & Murray LLP December 10, 2024 (GLOBE NEWSWIRE) As the deadline of January 13, 2025 approaches, investors of PACS Group Inc. are being reminded by Glancy Prongay & Murray LLP to file a lead plaintiff motion in the class action lawsuit. This lawsuit has…
The Impact of RBA Governor’s Comments on the AUD/USD Pair Introduction In Tuesday’s European session, the AUD/USD pair dipped below the crucial support level of 0.6400. This decline was primarily driven by Reserve Bank of Australia (RBA) Governor Michele Bullock’s less-hawkish interest rate guidance, following the decision to keep the OCR unchanged at 4.35% for…
The Impact of Home Chef on Home Cooks in 2024 Reflecting on a Year of Culinary Adventure In the fast-paced world we live in, convenience is key. This is especially true when it comes to meal preparation. Home Chef, the leading meal delivery service, has been at the forefront of providing simple and delicious meal…
Rockville and Suzhou: A Biopharmaceutical Marvel The Latest Breakthrough in Cancer Treatment Lisaftoclax (APG-2575) Shows Promise for Myelodysplastic Syndrome Patients Exciting news has emerged from the headquarters of Ascentage Pharma in Rockville, Maryland, and their research facility in Suzhou, China. The global biopharmaceutical company has announced the release of follow-up safety and efficacy data for…
Long Island Couple Gets Engaged in Surprise Holiday Proposal A Magical Moment on Main Street By: Anonymous After marching in Patchogue’s nighttime holiday parade on Nov. 30, Gabriela Manfredi and Robinson Cruthers went back to their office at the arts council to freshen up in preparation for hitting Main Street. “Really everyone just started dispersing,”…
First patient dosed with IDE161 and KEYTRUDA® Combination in Endometrial Cancer Trial IDEAYA Biosciences Announces Groundbreaking Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif., Dec. 10, 2024 /PRNewswire/ — IDEAYA Biosciences, a leading precision medicine oncology company, has marked a significant milestone by dosing the first patient in a Phase 1 clinical trial to evaluate…
Welcome to the Exciting World of CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)! Breaking News: New Results from the Phase 3 CARTITUDE-4 Study Exciting Developments in the Treatment of Multiple Myeloma Are you ready to dive into the world of cutting-edge medical advancements? Well, hold onto your hats because Johnson & Johnson has just announced groundbreaking results from…
